{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:37:30Z","timestamp":1782513450393,"version":"3.54.5"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["2R01CA151610"],"award-info":[{"award-number":["2R01CA151610"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH\u201018\u20101\u20100067"],"award-info":[{"award-number":["W81XWH\u201018\u20101\u20100067"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12020-020-02197-5","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T15:20:56Z","timestamp":1582039256000},"page":"6-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review"],"prefix":"10.1007","volume":"68","author":[{"given":"Harsh","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Arruarana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0921-7623","authenticated-orcid":false,"given":"Edward","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"issue":"1","key":"2197_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/jsm.12363","volume":"11","author":"G Heylens","year":"2014","unstructured":"G. Heylens, C. Verroken, S. De Cock, G. T\u2019Sjoen, G. De Cuypere, Effects of different steps in gender reassignment therapy on psychopathology: a prospective study of persons with a gender identity disorder. J. Sex. Med. 11(1), 119\u2013126 (2014)","journal-title":"J. Sex. Med."},{"issue":"7","key":"2197_CR2","first-page":"30","volume":"35","author":"L Hashemi","year":"2018","unstructured":"L. Hashemi, J. Weinreb, A.K. Weimer, R.L. Weiss, Transgender care in the primary care setting: a review of guidelines and literature. Fed. Pract. 35(7), 30\u201337 (2018)","journal-title":"Fed. Pract."},{"issue":"1","key":"2197_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40134-018-0260-1","volume":"6","author":"EB Sonnenblick","year":"2018","unstructured":"E.B. Sonnenblick, A.D. Shah, Z. Goldstein, T. Reisman, Breast imaging of transgender individuals: a review. Curr. Radiol. Rep. 6(1), 1 (2018)","journal-title":"Curr. Radiol. Rep."},{"issue":"12","key":"2197_CR4","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-018-0973-0","volume":"20","author":"HB Nguyen","year":"2018","unstructured":"H.B. Nguyen, A.M. Chavez, E. Lipner, L. Hantsoo, S.L. Kornfield, R.D. Davies, C.N. Epperson, Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition. Curr. Psychiatry Rep. 20(12), 110 (2018)","journal-title":"Curr. Psychiatry Rep."},{"issue":"11","key":"2197_CR5","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","volume":"102","author":"WC Hembree","year":"2017","unstructured":"W.C. Hembree, P.T. Cohen-Kettenis, L. Gooren, S.E. Hannema, W.J. Meyer, M.H. Murad, S.M. Rosenthal, J.D. Safer, V. Tangpricha, G.G. T\u2019Sjoen, Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 102(11), 3869\u20133903 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2197_CR6","doi-asserted-by":"crossref","unstructured":"I. Gardner, J.D. Safer, Progress on the road to better medical care for transgender patients. Current Opinion in Endocrinology, Diabetes and Obesity 20(6), 553\u2013558 (2013)","DOI":"10.1097\/01.med.0000436188.95351.4d"},{"key":"2197_CR7","unstructured":"J.P. Cunha, W.C. Shiel, Testosterone Replacement Therapy: Side Effects, Dosages, Treatment, Interactions, Warnings. RxList, RxList. Feb 21th, 2017. https:\/\/www.rxlist.com\/consumer_testosterone-medication\/drugs-condition.htm"},{"key":"2197_CR8","unstructured":"Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Rockville, Md.: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Office of Generic Drugs, 2018. Internet resource"},{"issue":"6","key":"2197_CR9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.21037\/tau.2016.07.10","volume":"5","author":"JJ Shoskes","year":"2016","unstructured":"J.J. Shoskes, M.K. Wilson, M.L. Spinner, Pharmacology of testosterone replacement therapy preparations. Transl Androl Urol. 5(6), 834\u2013843 (2016)","journal-title":"Transl Androl Urol."},{"issue":"3","key":"2197_CR10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1152\/physrev.00018.2016","volume":"97","author":"PS Cooke","year":"2017","unstructured":"P.S. Cooke, M.K. Nanjappa, C. Ko, G.S. Prins, R.A. Hess, Estrogens in male physiology. Physiol. Rev. 97(3), 995\u20131043 (2017)","journal-title":"Physiol. Rev."},{"issue":"2","key":"2197_CR11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.mce.2011.09.026","volume":"348","author":"DA Gibson","year":"2012","unstructured":"D.A. Gibson, P.T. Saunders, Estrogen dependent signaling in reproductive tissues\u2014a role for estrogen receptors and estrogen related receptors. Mol. Cell. Endocrinol. 348(2), 361\u2013372 (2012)","journal-title":"Mol. Cell. Endocrinol."},{"key":"2197_CR12","doi-asserted-by":"crossref","unstructured":"T. Deli, M. Orosz, A. Jakab, Hormone replacement therapy in cancer survivors\u2014review of the literature. Pathol. Oncol. Res. (2019)","DOI":"10.1007\/s12253-018-00569-x"},{"issue":"3","key":"2197_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, J. Ockene; Writing Group for the Women\u2019s Health Initiative I, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288(3), 321\u2013333 (2002)","journal-title":"JAMA"},{"issue":"4","key":"2197_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrclinonc.2017.207","volume":"15","author":"I Vaz-Luis","year":"2018","unstructured":"I. Vaz-Luis, A.H. Partridge, Exogenous reproductive hormone use in breast cancer survivors and previvors. Nat. Rev. Clin. Oncol. 15(4), 249\u2013261 (2018)","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2197_CR15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2017.07.012","volume":"84","author":"J Simin","year":"2017","unstructured":"J. Simin, R. Tamimi, J. Lagergren, H.O. Adami, N. Brusselaers, Menopausal hormone therapy and cancer risk: an overestimated risk? Eur. J. Cancer 84, 60\u201368 (2017)","journal-title":"Eur. J. Cancer"},{"issue":"9084","key":"2197_CR16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer T","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer T, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 350(9084), 1047\u20131059 (1997)","journal-title":"Lancet."},{"issue":"4","key":"2197_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-8587(16)30319-9","volume":"5","author":"V Tangpricha","year":"2017","unstructured":"V. Tangpricha, M. den Heijer, Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol. 5(4), 291\u2013300 (2017)","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"2197_CR18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","volume":"5","author":"MS Irwig","year":"2017","unstructured":"M.S. Irwig, Testosterone therapy for transgender men. Lancet Diabetes Endocrinol. 5(4), 301\u2013311 (2017)","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"2197_CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-40-3-367","volume":"40","author":"A Nimrod","year":"1975","unstructured":"A. Nimrod, K.J. Ryan, Aromatization of androgens by human abdominal and breast fat tissue. J. Clin. Endocrinol. Metab. 40(3), 367\u2013372 (1975)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2197_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4158\/EP-2017-0203","volume":"24","author":"KJ Chan","year":"2018","unstructured":"K.J. Chan, D. Jolly, J.J. Liang, J.D. Weinand, J.D. Safer, Estrogen levels do not rise with testosterone treatment for transgender men. Endocr. Pract. 24(4), 329\u2013333 (2018)","journal-title":"Endocr. Pract."},{"issue":"4","key":"2197_CR21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","volume":"20","author":"M Grynberg","year":"2010","unstructured":"M. Grynberg, R. Fanchin, G. Dubost, J.C. Colau, C. Bremont-Weil, R. Frydman, J.M. Ayoubi, Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod. Biomed. Online 20(4), 553\u2013558 (2010)","journal-title":"Reprod. Biomed. Online"},{"issue":"8","key":"2197_CR22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1369\/jhc.6A6928.2006","volume":"54","author":"MH Slagter","year":"2006","unstructured":"M.H. Slagter, L.J. Gooren, A. Scorilas, C.D. Petraki, E.P. Diamandis, Effects of long-term androgen administration on breast tissue of female-to-male transsexuals. J. Histochem. Cytochem. 54(8), 905\u2013910 (2006)","journal-title":"J. Histochem. Cytochem."},{"issue":"4","key":"2197_CR23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","volume":"164","author":"H Asscheman","year":"2011","unstructured":"H. Asscheman, E.J. Giltay, J.A. Megens, W.P. de Ronde, M.A. van Trotsenburg, L.J. Gooren, A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur. J. Endocrinol. 164(4), 635\u2013642 (2011)","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"2197_CR24","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ejso.2018.06.035","volume":"44","author":"RL Hartley","year":"2018","unstructured":"R.L. Hartley, J.P. Stone, C. Temple-Oberle, Breast cancer in transgender patients: a systematic review. Part 1: male to female. Eur. J. Surg. Oncol. 44(10), 1455\u20131462 (2018)","journal-title":"Eur. J. Surg. Oncol."},{"issue":"10","key":"2197_CR25","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ejso.2018.06.021","volume":"44","author":"JP Stone","year":"2018","unstructured":"J.P. Stone, R.L. Hartley, C. Temple-Oberle, Breast cancer in transgender patients: a systematic review. Part 2: female to male. Eur. J. Surg. Oncol. 44(10), 1463\u20131468 (2018)","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"2197_CR26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","volume":"4","author":"MN Pollak","year":"2004","unstructured":"M.N. Pollak, E.S. Schernhammer, S.E. Hankinson, Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4(7), 505\u2013518 (2004)","journal-title":"Nat. Rev. Cancer"},{"key":"2197_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2015.09.002","volume":"28","author":"C Carter-Su","year":"2016","unstructured":"C. Carter-Su, J. Schwartz, L.S. Argetsinger, Growth hormone signaling pathways. Growth Horm. IGF Res. 28, 11\u201315 (2016)","journal-title":"Growth Horm. IGF Res."},{"issue":"34","key":"2197_CR28","doi-asserted-by":"crossref","first-page":"21172","DOI":"10.1016\/S0021-9258(17)45342-7","volume":"265","author":"AJ Stewart","year":"1990","unstructured":"A.J. Stewart, M.D. Johnson, F.E. May, B.R. Westley, Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem. 265(34), 21172\u201321178 (1990)","journal-title":"J. Biol. Chem."},{"key":"2197_CR29","doi-asserted-by":"crossref","unstructured":"N. Nota, M. Klaver, C. Wiepjes, M. Dekker, A. Heijboer, M. Heijer Den, Increase in Insulin-like Growth Factor Levels During Cross-sex Hormone Treatment in Transgender Persons. 18th European Congress of Endocrinology (Munich, 2016)","DOI":"10.1530\/endoabs.41.EP961"},{"issue":"1","key":"2197_CR30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/er.2008-0022","volume":"30","author":"DL Kleinberg","year":"2009","unstructured":"D.L. Kleinberg, T.L. Wood, P.A. Furth, A.V. Lee, Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr. Rev. 30(1), 51\u201374 (2009)","journal-title":"Endocr. Rev."},{"issue":"2","key":"2197_CR31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/09513599809024960","volume":"12","author":"BW Hartmann","year":"1998","unstructured":"B.W. Hartmann, T. Laml, S. Kirchengast, A.E. Albrecht, J.C. Huber, Hormonal breast augmentation: prognostic relevance of insulin-like growth factor-I. Gynecol. Endocrinol. 12(2), 123\u2013127 (1998)","journal-title":"Gynecol. Endocrinol."},{"issue":"11","key":"2197_CR32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrendo.2014.139","volume":"10","author":"HS Narula","year":"2014","unstructured":"H.S. Narula, H.E. Carlson, Gynaecomastia\u2014pathophysiology, diagnosis and treatment. Nat. Rev. Endocrinol. 10(11), 684\u2013698 (2014)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"2197_CR33","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/en.2004-1360","volume":"146","author":"W Ruan","year":"2005","unstructured":"W. Ruan, M.E. Monaco, D.L. Kleinberg, Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 146(3), 1170\u20131178 (2005)","journal-title":"Endocrinology"},{"issue":"3","key":"2197_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1005998832636","volume":"47","author":"DL Kleinberg","year":"1998","unstructured":"D.L. Kleinberg, Role of IGF-I in normal mammary development. Breast Cancer Res. Treat. 47(3), 201\u2013208 (1998)","journal-title":"Breast Cancer Res. Treat."},{"issue":"16","key":"2197_CR35","first-page":"6276","volume":"61","author":"T Nickerson","year":"2001","unstructured":"T. Nickerson, F. Chang, D. Lorimer, S.P. Smeekens, C.L. Sawyers, M. Pollak, In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res. 61(16), 6276\u20136280 (2001)","journal-title":"Cancer Res."},{"issue":"10","key":"2197_CR36","first-page":"2942","volume":"62","author":"GO Hellawell","year":"2002","unstructured":"G.O. Hellawell, G.D. Turner, D.R. Davies, R. Poulsom, S.F. Brewster, V.M. Macaulay, Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res. 62(10), 2942\u20132950 (2002)","journal-title":"Cancer Res."},{"issue":"4","key":"2197_CR37","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0002-9440(10)64071-0","volume":"158","author":"M Gebre-Medhin","year":"2001","unstructured":"M. Gebre-Medhin, L.G. Kindblom, H. Wennbo, J. Tornell, J.M. Meis-Kindblom, Growth hormone receptor is expressed in human breast cancer. Am. J. Pathol. 158(4), 1217\u20131222 (2001)","journal-title":"Am. J. Pathol."},{"key":"2197_CR38","unstructured":"J.E. Hall, Guyton and Hall textbook of medical physiology. 13th edn. (Elsevier, Philadelphia, PA)"},{"issue":"2","key":"2197_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0303-7207(97)00063-4","volume":"129","author":"A Pezet","year":"1997","unstructured":"A. Pezet, H. Buteau, P.A. Kelly, M. Edery, The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor. Mol Cell Endocrinol. 129(2), 199\u2013208 (1997)","journal-title":"Mol Cell Endocrinol."},{"issue":"10","key":"2197_CR40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/bies.20468","volume":"28","author":"S Gerlo","year":"2006","unstructured":"S. Gerlo, J.R. Davis, D.L. Mager, R. Kooijman, Prolactin in man: a tale of two promoters. Bioessays 28(10), 1051\u20131055 (2006)","journal-title":"Bioessays"},{"issue":"2","key":"2197_CR41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/jc.2002-021255","volume":"88","author":"M Zinger","year":"2003","unstructured":"M. Zinger, M. McFarland, N. Ben-Jonathan, Prolactin expression and secretion by human breast glandular and adipose tissue explants. J. Clin. Endocrinol. Metab. 88(2), 689\u2013696 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2197_CR42","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/jid.2008.348","volume":"129","author":"K Foitzik","year":"2009","unstructured":"K. Foitzik, E.A. Langan, R. Paus, Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J. Investig. Dermatol. 129(5), 1071\u20131087 (2009)","journal-title":"J. Investig. Dermatol."},{"issue":"4","key":"2197_CR43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1172\/JCI119204","volume":"99","author":"MT Nevalainen","year":"1997","unstructured":"M.T. Nevalainen, E.M. Valve, P.M. Ingleton, M. Nurmi, P.M. Martikainen, P.L. Harkonen, Prolactin and prolactin receptors are expressed and functioning in human prostate. J. Clin. Investig. 99(4), 618\u2013627 (1997)","journal-title":"J. Clin. Investig."},{"issue":"1","key":"2197_CR44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/joe.0.1710085","volume":"171","author":"IG Camarillo","year":"2001","unstructured":"I.G. Camarillo, G. Thordarson, J.G. Moffat, K.M. Van Horn, N. Binart, P.A. Kelly, F. Talamantes, Prolactin receptor expression in the epithelia and stroma of the rat mammary gland. J. Endocrinol. 171(1), 85\u201395 (2001)","journal-title":"J. Endocrinol."},{"issue":"1","key":"2197_CR45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ecl.2007.10.013","volume":"37","author":"T Mancini","year":"2008","unstructured":"T. Mancini, F.F. Casanueva, A. Giustina, Hyperprolactinemia and prolactinomas. Endocrinol. Metab. Clin. N. Am. 37(1), 67\u201399 (2008)","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"3","key":"2197_CR46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81277-5","volume":"84","author":"JN Ihle","year":"1996","unstructured":"J.N. Ihle, STATs: signal transducers and activators of transcription. Cell 84(3), 331\u2013334 (1996)","journal-title":"Cell"},{"issue":"4","key":"2197_CR47","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0889-8529(18)30070-7","volume":"23","author":"AR Glass","year":"1994","unstructured":"A.R. Glass, Gynecomastia. Endocrinol. Metab. Clin. N. Am. 23(4), 825\u2013837 (1994)","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"2","key":"2197_CR48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/2230-8210.129104","volume":"18","author":"N Cuhaci","year":"2014","unstructured":"N. Cuhaci, S.B. Polat, B. Evranos, R. Ersoy, B. Cakir, Gynecomastia: clinical evaluation and management. Indian J. Endocrinol. Metab. 18(2), 150\u2013158 (2014)","journal-title":"Indian J. Endocrinol. Metab."},{"key":"2197_CR49","first-page":"249","volume":"162","author":"BM Stringer","year":"1989","unstructured":"B.M. Stringer, J. Rowson, E.D. Williams, Effect of raised serum prolactin on breast development. J. Anat. 162, 249\u2013261 (1989)","journal-title":"J. Anat."},{"issue":"10","key":"2197_CR50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-8587(17)30099-2","volume":"5","author":"S Mahfouda","year":"2017","unstructured":"S. Mahfouda, J.K. Moore, A. Siafarikas, F.D. Zepf, A. Lin, Puberty suppression in transgender children and adolescents. Lancet Diabetes Endocrinol. 5(10), 816\u2013826 (2017)","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"2197_CR51","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S1470-2045(05)70464-2","volume":"6","author":"G Di Lorenzo","year":"2005","unstructured":"G. Di Lorenzo, R. Autorino, S. Perdona, S. De Placido, Management of gynaecomastia in patients with prostate cancer: a systematic review. Lancet Oncol. 6(12), 972\u2013979 (2005)","journal-title":"Lancet Oncol."},{"key":"2197_CR52","unstructured":"B.P.C. Kreukels, T.D. Steensma, A.L.C.D. Vries, Gender Dysphoria and Disorders of Sex Development: Progress in Care and Knowledge (Springer, Heidelberg)"},{"issue":"8","key":"2197_CR53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1524-6175.2004.3735.x","volume":"6","author":"A Mosenkis","year":"2004","unstructured":"A. Mosenkis, R.R. Townsend, Gynecomastia and antihypertensive therapy. J. Clin. Hypertens. 6(8), 469\u2013470 (2004)","journal-title":"J. Clin. Hypertens."},{"issue":"6","key":"2197_CR54","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","volume":"72","author":"M Gil","year":"2011","unstructured":"M. Gil, B. Oliva, J. Timoner, M.A. Macia, V. Bryant, F.J. de Abajo, Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study. Br. J. Clin. Pharmacol. 72(6), 965\u2013968 (2011)","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"2197_CR55","doi-asserted-by":"crossref","first-page":"pii: e20173742","DOI":"10.1542\/peds.2017-3742","volume":"141","author":"D Chew","year":"2018","unstructured":"D. Chew, J. Anderson, K. Williams, T. May, K. Pang, Hormonal treatment in young people with gender dysphoria: a systematic review. Pediatrics. 141(4), pii: e20173742 (2018)","journal-title":"Pediatrics."},{"issue":"2","key":"2197_CR56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archinte.1988.00380020123017","volume":"148","author":"LA Tanner","year":"1988","unstructured":"L.A. Tanner, L.A. Bosco, Gynecomastia associated with calcium channel blocker therapy. Arch. Intern. Med. 148(2), 379\u2013380 (1988)","journal-title":"Arch. Intern. Med."},{"issue":"8","key":"2197_CR57","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1592\/phco.26.8.1165","volume":"26","author":"KB Hammons","year":"2006","unstructured":"K.B. Hammons, R.F. Edwards, W.Y. Rice, Golf-inhibiting gynecomastia associated with atorvastatin therapy. Pharmacotherapy 26(8), 1165\u20131168 (2006)","journal-title":"Pharmacotherapy"},{"issue":"6723","key":"2197_CR58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.300.6723.541","volume":"300","author":"Y Nakamura","year":"1990","unstructured":"Y. Nakamura, K. Yoshimoto, S. Saima, Gynaecomastia induced by angiotensin converting enzyme inhibitor. BMJ 300(6723), 541 (1990)","journal-title":"BMJ"},{"issue":"8","key":"2197_CR59","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM195302192480802","volume":"248","author":"EB Lewinn","year":"1953","unstructured":"E.B. Lewinn, Gynecomastia during digitalis therapy; report of eight additional cases with liver-function studies. N. Engl. J. Med. 248(8), 316\u2013320 (1953)","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"2197_CR60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM199609123351116","volume":"335","author":"L Green","year":"1996","unstructured":"L. Green, D.K. Wysowski, J.L. Fourcroy, Gynecomastia and breast cancer during finasteride therapy. N. Engl. J. Med. 335(11), 823 (1996)","journal-title":"N. Engl. J. Med."},{"key":"2197_CR61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/CLEP.S124674","volume":"9","author":"KW Hagberg","year":"2017","unstructured":"K.W. Hagberg, H.A. Divan, S.C. Fang, J.C. Nickel, S.S. Jick, Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia. Clin. Epidemiol. 9, 83\u201391 (2017)","journal-title":"Clin. Epidemiol."},{"issue":"9","key":"2197_CR62","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1468-1293.2010.00831.x","volume":"11","author":"MJ Sikora","year":"2010","unstructured":"M.J. Sikora, J.M. Rae, M.D. Johnson, Z. Desta, Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth. HIV Med. 11(9), 603\u2013607 (2010)","journal-title":"HIV Med."},{"issue":"1","key":"2197_CR63","first-page":"1","volume":"29","author":"M Chiba","year":"2001","unstructured":"M. Chiba, L. Jin, W. Neway, J.P. Vacca, J.R. Tata, K. Chapman, J.H. Lin, P450 interaction with HIV protease inhibitors: relationship between metabolic stability, inhibitory potency, and P450 binding spectra. Drug Metab. Dispos. 29(1), 1\u20133 (2001)","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"2197_CR64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/AAC.23.2.207","volume":"23","author":"DS Grosso","year":"1983","unstructured":"D.S. Grosso, T.W. Boyden, R.W. Pamenter, D.G. Johnson, D.A. Stevens, J.N. Galgiani, Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins. Antimicrob. Agents Chemother. 23(2), 207\u2013212 (1983)","journal-title":"Antimicrob. Agents Chemother."},{"issue":"22","key":"2197_CR65","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1001\/jama.1985.03360220083034","volume":"254","author":"TC Fagan","year":"1985","unstructured":"T.C. Fagan, D.G. Johnson, D.S. Grosso, Metronidazole-induced gynecomastia. JAMA 254(22), 3217 (1985)","journal-title":"JAMA"},{"key":"2197_CR66","first-page":"390","volume":"56","author":"R Dixit","year":"2008","unstructured":"R. Dixit, S. Sharma, C.L. Nawal, Gynaecomastia during antituberculosis chemotherapy with isoniazid. J. Assoc. Physicians India 56, 390\u2013391 (2008)","journal-title":"J. Assoc. Physicians India"},{"issue":"11","key":"2197_CR67","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1590\/S1806-37132008001100014","volume":"34","author":"N Morrone","year":"2008","unstructured":"N. Morrone, N. Morrone Jr, A.G. Braz, J.A. Maia, Gynecomastia: a rare adverse effect of isoniazid. J. Bras. Pneumol. 34(11), 978\u2013981 (2008)","journal-title":"J. Bras. Pneumol."},{"issue":"6927","key":"2197_CR68","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/bmj.308.6927.503","volume":"308","author":"LA Garcia Rodriguez","year":"1994","unstructured":"L.A. Garcia Rodriguez, H. Jick, Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ 308(6927), 503\u2013506 (1994)","journal-title":"BMJ"},{"issue":"2","key":"2197_CR69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/gut.20.2.154","volume":"20","author":"RW Spence","year":"1979","unstructured":"R.W. Spence, L.R. Celestin, Gynaecomastia associated with cimetidine. Gut 20(2), 154\u2013157 (1979)","journal-title":"Gut"},{"issue":"9964","key":"2197_CR70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0140-6736(14)60833-3","volume":"385","author":"T Poteat","year":"2015","unstructured":"T. Poteat, A.L. Wirtz, A. Radix, A. Borquez, A. Silva-Santisteban, M.B. Deutsch, S.I. Khan, S. Winter, D. Operario, HIV risk and preventive interventions in transgender women sex workers. Lancet 385(9964), 274\u2013286 (2015)","journal-title":"Lancet"},{"issue":"3","key":"2197_CR71","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1473-3099(12)70315-8","volume":"13","author":"SD Baral","year":"2013","unstructured":"S.D. Baral, T. Poteat, S. Stromdahl, A.L. Wirtz, T.E. Guadamuz, C. Beyrer, Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect. Dis. 13(3), 214\u2013222 (2013)","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl 3","key":"2197_CR72","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1097\/QAI.0000000000001086","volume":"72","author":"KH Mayer","year":"2016","unstructured":"K.H. Mayer, B. Grinsztejn, W.M. El-Sadr, Transgender people and HIV prevention: what we know and what we need to know, a call to action. J. Acquir. Immune Defic. Syndr. 72(Suppl 3), S207\u2013S209 (2016)","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"2197_CR73","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.socscimed.2015.11.010","volume":"147","author":"JM White Hughto","year":"2015","unstructured":"J.M. White Hughto, S.L. Reisner, J.E. Pachankis, Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc. Sci. Med. 147, 222\u2013231 (2015)","journal-title":"Soc. Sci. Med."},{"issue":"4","key":"2197_CR74","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1525\/srsp.2007.4.4.36","volume":"4","author":"SJ Hwahng","year":"2007","unstructured":"S.J. Hwahng, L. Nuttbrock, Sex workers, fem queens, and cross-dressers: differential marginalizations and HIV vulnerabilities among three ethnocultural male-to-female transgender communities in New York City. Sex. Res. Soc. Policy 4(4), 36\u201359 (2007)","journal-title":"Sex. Res. Soc. Policy"},{"issue":"6","key":"2197_CR75","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2524.2009.00866.x","volume":"17","author":"S Addis","year":"2009","unstructured":"S. Addis, M. Davies, G. Greene, S. Macbride-Stewart, M. Shepherd, The health, social care and housing needs of lesbian, gay, bisexual and transgender older people: a review of the literature. Health Soc. Care Commun. 17(6), 647\u2013658 (2009)","journal-title":"Health Soc. Care Commun."},{"issue":"10","key":"2197_CR76","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2105\/AJPH.2012.300796","volume":"103","author":"J Bradford","year":"2013","unstructured":"J. Bradford, S.L. Reisner, J.A. Honnold, J. Xavier, Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am. J. Public Health 103(10), 1820\u20131829 (2013)","journal-title":"Am. J. Public Health"},{"issue":"8","key":"2197_CR77","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s10508-014-0368-1","volume":"43","author":"JB Fletcher","year":"2014","unstructured":"J.B. Fletcher, K.A. Kisler, C.J. Reback, Housing status and HIV risk behaviors among transgender women in Los Angeles. Arch. Sex. Behav. 43(8), 1651\u20131661 (2014)","journal-title":"Arch. Sex. Behav."},{"issue":"2","key":"2197_CR78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1353\/hpu.2005.0038","volume":"16","author":"SP Kurtz","year":"2005","unstructured":"S.P. Kurtz, H.L. Surratt, M.C. Kiley, J.A. Inciardi, Barriers to health and social services for street-based sex workers. J. Health Care Poor Underserv. 16(2), 345\u2013361 (2005)","journal-title":"J. Health Care Poor Underserv."},{"issue":"2","key":"2197_CR79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/15299732.2014.867572","volume":"15","author":"KL Nadal","year":"2014","unstructured":"K.L. Nadal, K.C. Davidoff, W. Fujii-Doe, Transgender women and the sex work industry: roots in systemic, institutional, and interpersonal discrimination. J. Trauma Dissociation 15(2), 169\u2013183 (2014)","journal-title":"J. Trauma Dissociation"},{"issue":"2","key":"2197_CR80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MED.0000000000000227","volume":"23","author":"JD Safer","year":"2016","unstructured":"J.D. Safer, E. Coleman, J. Feldman, R. Garofalo, W. Hembree, A. Radix, J. Sevelius, Barriers to healthcare for transgender individuals. Curr. Opin. Endocrinol. Diabetes Obes. 23(2), 168\u2013171 (2016)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"4","key":"2197_CR81","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2105\/AJPH.2007.132035","volume":"99","author":"NF Sanchez","year":"2009","unstructured":"N.F. Sanchez, J.P. Sanchez, A. Danoff, Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am. J. Public Health 99(4), 713\u2013719 (2009)","journal-title":"Am. J. Public Health"},{"issue":"4","key":"2197_CR82","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4158\/EP13014.OR","volume":"19","author":"JD Safer","year":"2013","unstructured":"J.D. Safer, E.N. Pearce, A simple curriculum content change increased medical student comfort with transgender medicine. Endocr. Pract. 19(4), 633\u2013637 (2013)","journal-title":"Endocr. Pract."},{"issue":"10","key":"2197_CR83","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.4158\/EP15777.OR","volume":"21","author":"DD Thomas","year":"2015","unstructured":"D.D. Thomas, J.D. Safer, A simple intervention raised resident-physician willingness to assist transgender patients seeking hormone therapy. Endocr. Pract. 21(10), 1134\u20131142 (2015)","journal-title":"Endocr. Pract."},{"issue":"5","key":"2197_CR84","doi-asserted-by":"crossref","first-page":"pii: E88","DOI":"10.3390\/brainsci8050088","volume":"8","author":"A Metastasio","year":"2018","unstructured":"A. Metastasio, A. Negri, G. Martinotti, O. Corazza, Transitioning bodies. The case of self-prescribing sexual hormones in gender affirmation in individuals attending psychiatric services. Brain Sci. 8(5), pii: E88 (2018)","journal-title":"Brain Sci."},{"key":"2197_CR85","volume":"365","author":"CJM de Blok","year":"2019","unstructured":"C.J.M. de Blok, C.M. Wiepjes, N.M. Nota, K. van Engelen, M.A. Adank, K.M.A. Dreijerink, E. Barbe, I. Konings, M. den Heijer, Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ 365, l1652 (2019)","journal-title":"BMJ"},{"issue":"11","key":"2197_CR86","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/iju.12214","volume":"20","author":"Y Kojima","year":"2013","unstructured":"Y. Kojima, N. Takahashi, N. Haga, M. Nomiya, T. Yanagida, K. Ishibashi, K. Aikawa, D.I. Lee, Urinary incontinence after robot-assisted radical prostatectomy: pathophysiology and intraoperative techniques to improve surgical outcome. Int. J. Urol. 20(11), 1052\u20131063 (2013)","journal-title":"Int. J. Urol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-020-02197-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T23:50:13Z","timestamp":1613692213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-020-02197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02197-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,17]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals or human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}